Henderson N, Markwick LJ, Elshaw SR, Freyer AM, Knox AJ, Johnson SR. Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration. Am J Physiol Lung Cell Mol Physiol 292: L1030-L1038, 2007. First published December 22, 2006; doi:10.1152/ajplung.00317.2006.-Increased proinflammatory mediators and ECM deposition are key features of the airways in asthma. Matrix metalloproteinases (MMPs) are produced by airway smooth muscle (ASM) cells and have multiple roles in inflammation and tissue remodeling. We hypothesized that components of the asthmatic airway would stimulate MMP production and activation by ASM and contribute to airway remodeling. We measured human ASM-derived MMP mRNA, protein, and activity by real-time RT-PCR, zymography, Western blotting, and MMP activity assay. Collagen I and thrombin caused a synergistic increase in MMP-2 protein and total MMP activity but paradoxically decreased MMP-2 mRNA. Additionally, collagen I activated MMP-2 in culture supernatants independent of the cell surface. Together, collagen I and thrombin strongly enhanced MMP-14 mRNA and protein but had no effect individually, suggesting increased MMP-14, the activating protease for MMP-2, may be partially responsible for MMP-2 activation. Furthermore, collagen I reduced tissue inhibitor of metalloproteinase-2 protein (TIMP-2). We examined the role of MMPs in functions of ASM related to airway remodeling and found migration and proliferation were MMP dependent, whereas adhesion and apoptosis were not. Ilomastat inhibited migration by 25%, which was also inhibited by TIMPs 1-4 and increased by the MMP-2 activator thrombin. These in vitro findings suggest that the environment within the airways of patients with asthma enhances MMP-2 and -14 protein and activity by a complex interaction of transcriptional and posttranscriptional mechanisms, which may contribute to ASM migration. matrix metalloproteinases; asthma PATIENTS WITH ASTHMA DEVELOP structural airway changes termed remodeling. Starting in infancy, remodeling is categorized by airway smooth muscle (ASM) hypertrophy, hyperplasia, increased subepithelial myofibroblasts, altered ECM deposition, infiltration of ASM by mast cells, increased mucosal vascularity, epithelial shedding, metaplasia, and mucus gland hyperplasia (1,22,43). Remodeling results in bronchial hyperresponsiveness and airflow obstruction and, therefore, increased symptoms and use of asthma medication and health care resources (1, 34). The ASM cell is emerging as a key cell in airway remodeling being increased in both size and number in the airways of patients with asthma (4). Moreover, ASM cells produce ECM components (10), pro-and anti-inflammatory mediators, and growth factors of relevance to airway remodeling, including vascular endothelial growth factor (30), interleukin-8 (52), eotaxin (41), and prostaglandin E 2 (39). Thus the ASM cell is an important modulator of inflammation, inflammatory cell influx, and angiogenesis in the asthmatic ...